08:21 AM EDT, 08/26/2024 (MT Newswires) -- McKesson (MCK) said Monday it has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, also known as Core Ventures, a business and administrative services organization established by the Florida Cancer Specialists & Research Institute.

McKesson will spend about $2.49 billion in cash to acquire about 70% ownership in the organization. Following completion of the deal, Core Ventures will be part of the oncology platform, and its financial results will be reported within McKesson's US pharmaceutical segment, the company said.

Florida Cancer Specialists & Research Institute physicians will continue to retain a minority interest in Core Ventures, the company added.

Price: 552.46, Change: +0.31, Percent Change: +0.06